Combined intraarterial and systemic chemotherapy for intracerebral tumors
| Autor: | Brien Benoit, Zvonimir Grahovac, Herman Hugenholtz, M. T. Richard, Neville Russell, David J. Stewart |
|---|---|
| Rok vydání: | 1987 |
| Předmět: |
Adult
Glycerol medicine.medical_specialty Vincristine Adolescent Pulmonary toxicity medicine.medical_treatment Procarbazine Gastroenterology Bleomycin Glioma Internal medicine Antineoplastic Combined Chemotherapy Protocols medicine Humans Infusions Intra-Arterial Infusions Intravenous Aged Teniposide Chemotherapy Performance status business.industry Brain Neoplasms Middle Aged medicine.disease Chemotherapy regimen Carmustine Regimen Methotrexate Surgery Neurology (clinical) Cisplatin business medicine.drug |
| Zdroj: | Neurosurgery. 21:207 |
| ISSN: | 0148-396X |
| DOI: | 10.1097/00006123-198708000-00013 |
| Popis: | Twenty-six patients with intracerebral tumors (predominantly gliomas) were treated with intraarterial BCNU, VM-26, and cisplatin combined with the systemic administration of VM-26, methotrexate, vincristine, bleomycin, and procarbazine. Oral glycerol was given before i.v. VM-26. Twelve patients responded (46% of all patients and 63% of the fully evaluable patients). The response rate for gliomas was 50% if all patients were considered and 71% if only fully evaluable patients were considered. The response rate did not seem to be affected by glioma grade, prior chemotherapy, or pretreatment performance status. Median time to tumor progression for responders was 19 weeks. Median survival from initiation of treatment was 21 weeks for evaluable patients and 17 weeks for all patients. Median survival from initial diagnosis was 55 weeks. Myelosuppression was dose-limiting for the systemic chemotherapy. Reversible neurological toxicity was common, but tolerable. One patient developed ipsilateral blindness, and two patients developed prolonged neurological toxicity. Pulmonary toxicity was also seen. Vertebral artery infusions proved feasible, although difficult and more toxic than carotid infusions. Overall, this regimen was not more active than the intraarterial combination of BCNU, VM-26, and cisplatin without the systemic chemotherapy. Further studies of more intensive intracarotid therapy combined with different systemic drugs are being initiated. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|